Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Catholic University of the Sacred Heart |
---|---|
Information provided by: | Catholic University of the Sacred Heart |
ClinicalTrials.gov Identifier: | NCT00775762 |
This is a monocentric, randomized, opened study to assess the anti-inflammatory and anti-platelet effect of Clopidogrel and aspirin versus aspirin or clopidogrel alone in patients with symptomatic polyvascular disease and with multiple recurrent cardiovascular events.
Condition | Intervention | Phase |
---|---|---|
Polyvascular Disease Cardiovascular Disease |
Drug: aspirin Drug: clopidogrel Drug: clopidogrel plus aspirin |
Phase III |
Study Type: | Interventional |
Study Design: | Basic Science, Randomized, Open Label, Uncontrolled, Parallel Assignment |
Estimated Enrollment: | 213 |
Study Start Date: | November 2008 |
Estimated Study Completion Date: | December 2010 |
Estimated Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
aspirin: Active Comparator |
Drug: aspirin
Aspirin (75-100 mg)die for three months
|
clopidogrel: Active Comparator |
Drug: clopidogrel
Clopidogrel (75mg) die for three months
|
clopidogrel plus aspirin: Active Comparator |
Drug: clopidogrel plus aspirin
clopidogrel 75 mg die plus aspirin 75-100 mg for three months
|
Ages Eligible for Study: | 40 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Luigi M Biasucci, MD | lmbiasucci@virgilio.it |
Italy | |
Catholic University of the Sacred Heart, Department of Cardiovascular Medicine | |
Rome, Italy, 00135 |
Responsible Party: | Catholic University of the Sacred Heart ( Luigi Marzio Biasucci ) |
Study ID Numbers: | 2008-004626-17 |
Study First Received: | October 17, 2008 |
Last Updated: | October 17, 2008 |
ClinicalTrials.gov Identifier: | NCT00775762 History of Changes |
Health Authority: | Italy: Ethics Committee |
Symptomatic Polyvascular disease Multiple recurrent cardiovascular events |
Anti-Inflammatory Agents Cyclooxygenase Inhibitors Fibrinolytic Agents Cardiovascular Agents Recurrence Fibrin Modulating Agents Aspirin |
Analgesics, Non-Narcotic Clopidogrel Anti-Inflammatory Agents, Non-Steroidal Platelet Aggregation Inhibitors Analgesics Peripheral Nervous System Agents Antirheumatic Agents |
Anti-Inflammatory Agents Molecular Mechanisms of Pharmacological Action Cyclooxygenase Inhibitors Hematologic Agents Physiological Effects of Drugs Enzyme Inhibitors Fibrinolytic Agents Cardiovascular Agents Pharmacologic Actions Fibrin Modulating Agents Aspirin |
Analgesics, Non-Narcotic Sensory System Agents Clopidogrel Therapeutic Uses Platelet Aggregation Inhibitors Cardiovascular Diseases Anti-Inflammatory Agents, Non-Steroidal Analgesics Peripheral Nervous System Agents Antirheumatic Agents Central Nervous System Agents |